Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 233,381,593 papers from all fields of science
Search
Sign In
Create Free Account
AMN107
Known as:
AMN 107
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
nilotinib
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Pharmacokinetics Versus Intact Capsules/Tablets in Healthy Volun
G. Houghton
2017
Corpus ID: 55268343
OTHER PUBLICATIONS Hazarika et al., “Tasigna for chronic and accelerated phase Philadel phia chromosome positive chronic…
Expand
2008
2008
Acute myeloid leukemia-targeted toxins kill tumor cells by cell type-specific mechanisms and synergize with TRAIL to allow manipulation of the extent and mechanism of tumor cell death
H. Horita
,
A. Frankel
,
A. Thorburn
Leukemia
2008
Corpus ID: 22159977
Acute myeloid leukemia-targeted toxins kill tumor cells by cell type-specific mechanisms and synergize with TRAIL to allow…
Expand
2008
2008
Bullous sweet syndrome in a patient with t(9;22)(q34;q11)-positive chronic myeloid leukemia treated with the tyrosine kinase inhibitor nilotinib: interphase cytogenetic detection of BCR-ABL- positive…
K. Kaune
,
M. Baumgart
,
+8 authors
S. Emmert
Archives of Dermatology
2008
Corpus ID: 5140149
BACKGROUND An association of Sweet syndrome with chronic myeloid leukemia (CML) has been recently observed in patients treated…
Expand
2008
2008
Receptor Tyrosine Kinases as Targets for Treatment of Peripheral Nerve Sheath Tumors in NF 1 Patients
V. Mautner
2008
Corpus ID: 53869288
Abstract : NF1 is characterized by the appearance of multiple tumors of the peripheral nerve, and occasionally the malignant…
Expand
2008
2008
Arzneistoffprofil: Nilotinib
P. le Coutre
,
C. Petereit
,
H. Peters
Der Onkologe
2008
Corpus ID: 36940510
ZusammenfassungNilotinib (AMN107) ist ein neuer, hoch selektiver and potenter Aminopyrimidin-Inhibitor der BCR-ABL-Tyrosinkinase…
Expand
2007
2007
The effect of AMN107 on hepatocellular carcinoma
L. Lui
,
雷力恆.
2007
Corpus ID: 74423922
2006
2006
Resistance to Imatinib
D. Justus
,
Bubnoff Nikolas von
2006
Corpus ID: 204076190
2006
2006
Activity of AMN107 in Gleevec-resistant Leukemia
Cancer Biology & Therapy
2006
Corpus ID: 10910917
AMN107 Has Potent Activity In Leukemia Resistant to Gleevec MD Anderson News Release 12/11/05 ATLANTA - The targeted agent AMN107…
Expand
2005
2005
AMN107: a potential therapy in myeloproliferative disease
C. Lovegrove
Nature Clinical Practice Oncology
2005
Corpus ID: 40803459
Around 50% of patients with acute myeloid leukemia (AML) do not show chromosomal aberrations on conventional analysis. A study…
Expand
2005
2005
Neuroblastic tumors and the epigenome
R. Kirby
Nature Clinical Practice Oncology
2005
Corpus ID: 37693378
lymphoblastic leukemia. A study into the ability of AMN107 to inhibit the TEL-PDGFRβ and FIP1L1-PDGRFα fusion kinases, associated…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE